Celon Pharma S.A. (WSE:CLN)

Celon Pharma Revenue

Celon Pharma had revenue of 61.29M PLN in the quarter ending March 31, 2026, with 22.42% growth. This brings the company's revenue in the last twelve months to 225.60M, up 7.29% year-over-year. In the year 2024, Celon Pharma had annual revenue of 205.55M, down -4.25%.

• Revenue (ttm): 225.60M
• Revenue Growth: +7.29%
• P/S Ratio: 4.99
• Revenue / Employee: 398.58K
• Employees: 564
• Market Cap: 1.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	205.55M	-9.12M	-4.25%
Dec 31, 2023	214.66M	20.78M	10.72%
Dec 31, 2022	193.89M	-2.20M	-1.12%
Dec 31, 2021	196.09M	38.64M	24.54%
Dec 31, 2020	157.45M	55.20M	53.99%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error